UNSPSC 41141935: Catecholamines (total) test system

In this classification, Catecholamines (total) test system connotes a device used to measure Catecholamines (total) levels. US FDA regulates Catecholamines (total) test system under 21 CFR 862.1165 and under FDA product code CHT.

UNSPSC 41141935 Catecholamines (total) test system is a Commodity code that maps to forensic and clinical laboratory testing consumables, specifically immunoassay reagent kits, drug reference standards, and DNA screening materials used by state and local crime laboratories and public health agencies for toxicology, controlled-substance analysis, and evidentiary sample evaluation. State and local governments procure direct ELISA testing kits for substance screening (cannabinoids, opiates, amphetamines, benzodiazepines, and related compounds), certified reference materials meeting ISO/IEC 17025:2017 accreditation standards, and associated consumables such as phosphate-buffered saline solution and quality-control reagents. Issuing bodies include state departments of public safety, state health and human services commissions, county forensic laboratories, and state law enforcement agencies. The mix reflects both high-volume regulatory procurement at the state level (particularly in Texas and Florida) and specialized forensic infrastructure maintained by counties and state crime laboratories.

Recent activity spans Texas, Florida, and Illinois, with Texas Department of Public Safety, Texas Health and Human Services Commission, Pinellas County (Florida), and Illinois Department of Financial and Professional Regulation all soliciting under this code in 2026. Representative opportunities include the Texas Department of Public Safety's July 2026 IFB 405-26R0008445A for 12 line items of direct ELISA testing kits with response due July 23, 2026; Pinellas County's April 2026 Invitation to Quote #26-0305-ITQ for 131 line items of certified drug reference standards with delivery by June 1, 2026, funded through the Paul Coverdell Forensic Sciences Improvement Act Program ($49,034.00 for equipment and supplies); and Texas Health and Human Services Commission's January 2026 IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits with historical annual spend of $25,050.00 to $30,000.00. Set-aside preferences vary by jurisdiction — Pinellas County extends priority to Certified Small Business Enterprises, while Texas TDCJ requires HUB Subcontracting Plans. Response dates are typically two to three weeks from posting, and most solicitations require firm pricing held for 12 months with potential annual extension.